Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

EPA OKs drinking filtered water in Flint as CDC releases report detailing effects on children

It’s finally OK to drink the tap water in Flint, Mich.—but only if it’s filtered, according to a June 23 announcement from the Environmental Protection Agency.

Thumbnail

CDC awards $26M for research on hospital ‘superbugs’

Several academic hospitals have been awarded $26 million from the Centers for Disease Control and Prevention to research new ways to prevent hospital-acquired infections (HAIs), particularly those resistant to antibiotics

Patients unhappy with UnitedHealth’s limits on insulin pumps

A new deal between UnitedHealthcare and device maker Medtronic means fewer options for UnitedHealth customers who need insulin pumps to treat Type 1 diabetes.

Living organ donation can be ethical minefield

If someone is dying but could donate vital organs before life support was removed, can a spouse make someone a living donor without that person's direct consent?

State news: Calif. split on Aetna-Humana merger, N.Y. enacts opioid prescription limits

Here’s a roundup of the latest healthcare news from California, New York, Kentucky, Illinois and Indiana.

CDC failed to disclose lab mishaps to Congress

The Centers for Disease Control and Prevention (CDC) told Congress it left out 34 incident reports involving lab mistakes from information it provided to a congressional investigation in 2014, according to USA Today.

IT group wants interoperability standards for drug monitoring

As the House and Senate work in a conference committee on anti-opioid abuse legislation, a coalition called Health IT Now has asked lawmakers to lay out more specific standards on how different states’ prescription drug monitoring programs (PDMPs) will be interoperable. 

House passes Zika bill opposed by White House, Senate Dems

Legislation providing $1.1 billion in funding for anti-Zika virus efforts has passed in the House, but the Obama administration and the leader of the Senate Democrats are strongly criticizing the proposal.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup